Cetera Advisors LLC Novavax Inc Transaction History

Cetera Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$36.28 - $75.29 $2,176 - $4,517	-60 Reduced 0.79%	7,572 $389,000
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $17,711 - $36,296	254 Added 3.44%	7,632 $562,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $46,557 - $75,417	346 Added 4.92%	7,378 $1.06 Million
Q3 2021 Nov 16, 2021	BUY	$177.8 - $270.58 $54,940 - $83,609	309 Added 4.6%	7,032 $1.46 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $52,393 - $111,571	433 Added 6.88%	6,723 $1.43 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $221,553 - $627,382	-1,961 Reduced 23.77%	6,290 $1.14 Million
Q4 2020 Feb 17, 2021	BUY	$78.74 - $139.5 $11,102 - $19,669	141 Added 1.74%	8,251 $920,000
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $173,973 - $390,936	2,190 Added 36.99%	8,110 $879,000
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $82,051 - $494,971	5,920 New	5,920 $493,000

288

94.7M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $689M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.